The European Medicines Agency (“EMA”) has published a new guidance document for companies that wish to participate in the Adaptive Pathways initiative (“New Guidance”).

Adaptive Pathways

Adaptive Pathways was established as part of the EMA’s objective to improve timely access for patients to new medicinal products. Adaptive Pathways applies to medicinal products with the potential…